top of page
Zhou Lab
Advancing immunotherapy through intercellular communications
Research
Our lab studies how immune cells communicate with each other and with tumors, with the goal of engineering these interactions to develop next-generation cancer immunotherapies. Using CRISPR-based genome editing, synthetic receptor engineering, we dissect and reprogram intercellular signaling networks that govern immune activation, tolerance, and resistance to therapy.
bottom of page